Palavras-chave
Como Citar
Resumo
O bioestimulador de colágeno é um dos métodos mais procurados para melhorar a estética facial, permitindo a restauração de volumes e contornos perdidos na face com o passar dos anos. A hidroxiapatita de cálcio é um bioestimulador de colágeno injetável que estimula a produção endógena de colágeno através da ativação dos fibroblastos para a produção de novas fibras colágenas. Com base na relevância da CaHA no mercado estético atual, o objetivo desse trabalho foi avaliar a eficácia e segurança do bioestimulador de colágeno, Biocrystal do laboratório Biometil, na melhoria da qualidade da pele após injeção subcutânea. Nesse estudo foram tratadas 12 mulheres utilizando a técnica L invertido e a avaliação foi realizada pelas próprias pacientes utilizando a escala GAIS. Os resultados mostraram que a grande maioria das pacientes classificou de maneira positiva a melhoria da qualidade da pele (escala 2 de GAIS), porém foram relatados efeitos adversos, principalmente nos 3 primeiros dias. O produto Biocrystal da Biometil parece ter efeitos na melhoria da qualidade de pele, porém mais estudos são necessários para comprovar sua eficácia e segurança.
Referências
Abrouk, Michael et al. (2022), “Medical and aesthetic improvement of photodamaged skin by the combination of intense pulsed light and photodynamic therapy with 10% aminolevulinic acid hydrochloride gel, Lasers in Surgery and Medicine, 54 (1), 62-65.
Bass, Lawrence et al. (2010), “Calcium hydroxylapatite (Radiesse) for treatment of nasolabial folds: long-term safety and efficacy results”., Aesthet Surg J. , 30 (2), 235-238.
Casabona, Gabriela; MARCHESE, Paula (2017), “Calcium Hydroxylapatite Combined with Microneedling and Ascorbic Acid is Effective for Treating Stretch Marks.”, Plastic and reconstructive surgery. Global open, 5(9):1474.
Coleman, Kyle et al. (2008), “ Neocollagenesis after injection of calcium hydroxylapatite composition in a canine model”, Dermatologic Surgery, 34, 53-55.
Dadzie, Ophelia et al. (2008), “Adverse cutaneous reactions to soft tissue fillers – a review of the histological features”, J Cutan Pathol. 35(6), 536-48.
De Almeida, Ada Trindade et al. (2019), “Consensus recommendations for the use of hyperdiluted calcium hydroxyapatite (Radiesse) as a face and body biostimulatory agent. Plastic and Reconstructive Surgery Global Open”, 7(3).
Eviatar, Joseph et al. (2015), “Radiesse: advanced techniques and applications for a unique and versatile implant. Plastic and reconstructive surgery”, 136(5), 164-170.
González, Noelani; Goldberg, David (2019),” Evaluating the Effects of Injected Calcium Hydroxylapatite on Changes in Human Skin Elastin and Proteoglycan Formation”, Dermatologic Surgery, 45(4), 547-551.
Greco, Timothy et al. (2012), “Injectable fillers for volume replacement in the aging face”, Facial Plast Surg., 28(1), 8-20.
Guida, Stefania tal. (2020), “Hiperdiluted clacuim hydroxyapatite for skin laxity and celulite of the skin above the knee: A pilot study, Dermatologic Therapy, 33(6), 14076.
Hexsel, Doris et al. (2020), “Introducing the L-Lift—A Novel Approach to Treat Age-Related Facial Skin Ptosis Using A Collagen Stimulator”, Dermatologic Surgery, 46(8), n. 8, 1122-1124.
Loghem, Jani Van et al. (2015), “Calcium hydroxylapatite:over a decade of clinical experience”, J Clin Aesthet Dermatol., 8(1),38-49.
Kadouch, Jonathan (2017), “Calcium hydroxylapatite: A review on safety and complications”, Journal of cosmetic dermatology, 16(2), 152-161.
Varani, James et al. (2006), “Decreased collagen production in chronologically aged skin. Roles of age-dependent alteration in fibroblast function and defective mechanical stimulation”, Am J Pathol., 168(6), 1861-8.
Yutskovkaya, Yana; KOGAN, Evgeniya Alexandrovna (2017), “Improved Neocollagenesis and Skin Mechanical Properties After Injection of Diluted Calcium Hydroxylapatite in the Neck and Décolletage: A Pilot Study”, Journal of drugs in dermatology: JDD, 16,(1) , 68-74.
Yutskovkaya, Yana et al. (2014), “A randomized, split face, histomorphologic study, comparing a volumetric calcium hydroxyapatite and a hyaluronic acid-based dermal filler”., J Drugs, 13(9), 47-52.